AbbVie, Eli Lilly Beat Insurer's RICO Suit in Testosterone MDL

Law360 (February 15, 2019, 9:38 PM EST) -- An Illinois federal judge entered judgment in favor of AbbVie and other makers of testosterone replacement drugs in a Racketeer Influenced and Corrupt Organizations Act suit brought by an insurer on Thursday, saying there was no evidence the insurer was misled by the companies.

U.S. District Judge Matthew Kennelly granted the pharmaceutical companies’ motions for summary judgment in Medical Mutual of Ohio’s suit after finding the insurer hadn’t shown it was deceived by false information AbbVie Inc., Eli Lilly and Co., Endo Pharmaceuticals Inc., Actavis Inc. and Auxilium Pharmaceuticals Inc. disseminated about the safety and efficacy of their testosterone products....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!